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Abstract

Type 1 diabetes (T1D) is an autoimmune disease that results from the attack of auto-reactive lymphocytes (T-cells) on pancreatic beta cells causing hyperglycemia. Garcinia kola
(GK), an African herb, is believed to have anti-inflammatory abilities. We hypothesized that GK extract (GKE) will reduce the activity of pathogenic T-cells, thus having a potential
for prevention of T1D in a T1D mouse model. C57BL/6 mice were treated daily by GKE (100 mg/kg) added to their drinking water from 7 to 13 weeks of age, and diabetes was
induced by the administration of streptozotocin. The GKE effects were tested on T-cell composition (by using flow cytometry) and T-cell function (by performing T-cell
proliferation assays) in the treated and control mice. At the completion of the experiment, both control and treatment mice were euthanized, single cell suspension was prepared
from their spleens, and cell counts and viability obtained. T -cell proliferation was tested by culturing splenocytes with the addition of T-cell-specific mitogen concanavalin A, while
identification of T-cells and their respective subpopulations was performed by exposing splenic cells to fluorochrome-labeled antibodies that detect specific T-cell markers, and
their quantification was completed by laser-based flow cytometry. Our results showed that GKE treatment inhibited the proliferative capability of T-cells and decreased the
percentage of T-cells, as well as their subpopulations. In conclusion, our results show that GKE has a potential to act as an immunosuppressive T-cell agent that might positively
affect T1D development.

Objective
To study the effects of the Garcinia kola extract (GKE) treatment on T-cell composition and function in an experimental T1D mouse model.
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Figure 1. Cell counts (Trypan blue exclusion assay) presented as average

Figure 2. Cell viability data presented as average percentage
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Figure 3. T-cell proliferation index presented as average
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Figure 4. Immunophenotyping of splenocytes; average percentage
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Conclusion

Summary
GKE treatment’s effects:
• No significant change in cell counts and viability (Fig. 1 and 2)
• A trend of a decreased proliferation of T-cells (Fig. 3)
• Reduced numbers of T-cells, T-helpers and T-cytotoxic cells ( Fig. 4)

GKE treatment suppressed T-cell proliferative capacity and reduced
the numbers of T-cells as well as their subpopulations, supporting
our initial hypothesis. Our data suggest that GKE treatment might
prevent T1D development, however, ongoing experiments in our
laboratory did not confirm it.
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